Nomura Holdings’s Syndax Pharmaceuticals SNDX Stock Holding History

Nomura Holdings’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$420K	Sell	18,000 -40,000	-69%	-$869K	﹤0.01%	1413
2025 Q4	$1.22M	Buy	+58,000	New	+$1.01M	﹤0.01%	1269
2025 Q3	–	Sell	-27,000	Closed	-$253K	–	2063
2025 Q2	$253K	Hold	27,000	–	–	﹤0.01%	1267
2025 Q1	$332K	Buy	+27,000	New	+$381K	﹤0.01%	1583
2024 Q4	–	Sell	-40,000	Closed	-$770K	–	2382
2024 Q3	$770K	Buy	+40,000	New	+$826K	﹤0.01%	1174

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Nomura Holdings's SNDX Position: Q4 2024 in Review

Nomura Holdings sold out of Syndax Pharmaceuticals (SNDX) in Q4 2024, closing a stake of 21,849 shares — an estimated $421K sold.

Nomura Holdings first reported a position in SNDX in Q3 2024 and held it in 1 quarter. The position peaked at $421K in Q3 2024. 215 funds tracked by Wall St. Rank hold SNDX as of Q4 2024.

Nomura Holdings reported no remaining Syndax Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Nomura Holdings sold 21,849 Syndax Pharmaceuticals shares in Q4 2024, an estimated $421K.
Nomura Holdings first reported a position in Syndax Pharmaceuticals in Q3 2024 and held it in 1 quarter.
Nomura Holdings's Syndax Pharmaceuticals position peaked at $421K in Q3 2024.
215 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.